Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Purpose Numerous studies have examined non-adherence to adjuvant endocrine therapy in
women recovering from breast cancer, but none provides a comprehensive theory to explain …

Background Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral
disorder affecting approximately 10.0% of children and 6.5% of adolescents in the United …

Viloxazine is a recently approved, non-stimulant medication functions by inhibiting the
uptake of norepinephrine which has been seen to be decreased in patients with ADHD …

Viloxazine extended‐release capsules (viloxazine ER; Qelbree) is a novel nonstimulant,
recently approved by the US Food and Drug Administration for the treatment of ADHD in …

Many studies have demonstrated the short-term efficacy and tolerability of methylphenidate
treatment adolescents with attention deficit hyperactivity disorder (ADHD). Qualitative …

Objectives: This paper reviews the literature on intentional discontinuation of
psychostimulants in ADHD to summarize what is known about clinical course of controlled …

Background: The majority of existing shared decision making (SDM) models are yet to
explicitly account for emotion as an influencing factor to the SDM process. This study aimed …

Background: Shared decision making (SDM) is recognized as a person-centered approach
to improving health care quality and outcomes. Few digital interventions to improve SDM …

National and international guidelines on the treatment of attention deficit hyperactivity
disorder (ADHD) in children and adolescents call for annual reviews to assess continuing …